{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:27:30Z","timestamp":1789511250126,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP223 (233, 243) fa627005"],"award-info":[{"award-number":["JP223 (233, 243) fa627005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23H05451"],"award-info":[{"award-number":["23H05451"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K23256"],"award-info":[{"award-number":["24K23256"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s13346-025-01824-w","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:13:33Z","timestamp":1741349613000},"page":"3626-3641","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Harnessing the composition of lipid nanoparticles to selectively deliver mRNA to splenic immune cells for anticancer vaccination"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9722-3267","authenticated-orcid":false,"given":"Mahmoud A.","family":"Younis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser H. A.","family":"Elewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1568-9547","authenticated-orcid":false,"given":"Hideyoshi","family":"Harashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"1824_CR1","unstructured":"World Health Organization (WHO). COVID-19 significantly impacts health services for noncommunicable diseases. https:\/\/www.who.int\/news\/item\/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases. Accessed on 2024\/09\/03."},{"key":"1824_CR2","first-page":"1073","volume":"31","author":"A Haileamlak","year":"2021","unstructured":"Haileamlak A. The impact of COVID-19 on health and health systems. Ethiop J Health Sci. 2021;31:1073\u20134.","journal-title":"Ethiop J Health Sci"},{"key":"1824_CR3","doi-asserted-by":"publisher","first-page":"20220546","DOI":"10.1515\/ntrev-2022-0546","volume":"12","author":"AAH Abdellatif","year":"2023","unstructured":"Abdellatif AAH, Abdelfattah A, Younis MA, Aldalaan SM, Tawfeek HM. Chitosan-capped silver nanoparticles with potent and selective intrinsic activity against the breast cancer cells. Nanatechnol Reviews. 2023;12:20220546.","journal-title":"Nanatechnol Reviews"},{"issue":"2023","key":"1824_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics. Cancer J Clin. 2023;73(2023):17\u201348.","journal-title":"Cancer J Clin"},{"key":"1824_CR5","unstructured":"The Nobel Prize. The Nobel Prize in Physiology or Medicine 2018. https:\/\/www.nobelprize.org\/prizes\/medicine\/2018\/press-release\/. Accessed on 2024\/09\/04."},{"key":"1824_CR6","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","volume":"3","author":"MJ Lin","year":"2022","unstructured":"Lin MJ, Svensson-Arvelund J, Lubitz GS, Marabelle A, Melero I, Brown BD, Brody JD. Cancer vaccines: the next immunotherapy frontier. Nat Cancer. 2022;3:911\u201326.","journal-title":"Nat Cancer"},{"key":"1824_CR7","doi-asserted-by":"crossref","unstructured":"Gupta M, Wahi A, Sharma P, Nagpal R, Raina N, Kaurav M, Bhattacharya J, Rodrigues Oliveira SM, Dolma KG, Paul AK, de Pereira M, Wilairatana P, Rahmatullah M, Nissapatorn V. Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects, Vaccines. 2022;10.","DOI":"10.3390\/vaccines10122011"},{"key":"1824_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/PGPM.S431346","volume":"17","author":"MA Younis","year":"2024","unstructured":"Younis MA, Harashima H. Understanding gene involvement in hepatocellular carcinoma: implications for gene therapy and personalized medicine. Pharmacogenomics Personalized Med. 2024;17:193\u2013213.","journal-title":"Pharmacogenomics Personalized Med"},{"key":"1824_CR9","unstructured":"The Nobel Prize. The Nobel Prize in Physiology or Medicine 2023. https:\/\/www.nobelprize.org\/prizes\/medicine\/2023\/press-release\/. Accessed on 2024\/09\/04."},{"key":"1824_CR10","doi-asserted-by":"publisher","first-page":"114083","DOI":"10.1016\/j.addr.2021.114083","volume":"181","author":"MA Younis","year":"2022","unstructured":"Younis MA, Tawfeek HM, Abdellatif AAH, Abdel-Aleem JA, Harashima H. Clinical translation of nanomedicines: challenges, opportunities, and keys. Adv Drug Deliv Rev. 2022;181:114083.","journal-title":"Adv Drug Deliv Rev"},{"key":"1824_CR11","first-page":"113111","volume-title":"Lipid nanoparticles technology in vaccines: shaping the future of prophylactic medicine, colloids and surfaces","author":"AAH Abdellatif","year":"2023","unstructured":"Abdellatif AAH, Younis MA, Alsowinea AF, Abdallah EM, Abdel-Bakky MS, Al-Subaiyel A, Hassan YAH, Tawfeek HM. Lipid nanoparticles technology in vaccines: shaping the future of prophylactic medicine, colloids and surfaces. Volume 222. Biointerfaces: B; 2023. p. 113111."},{"key":"1824_CR12","doi-asserted-by":"crossref","unstructured":"Shimosakai R, Khalil IA, Kimura S, Harashima H. mRNA-Loaded lipid nanoparticles targeting immune cells in the spleen for use as Cancer vaccines. Pharmaceuticals. 2022;15:1017.","DOI":"10.3390\/ph15081017"},{"key":"1824_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jconrel.2019.01.001","volume":"295","author":"Y Sato","year":"2019","unstructured":"Sato Y, Hashiba K, Sasaki K, Maeki M, Tokeshi M, Harashima H. Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering SiRNAs in vivo. J Controlled Release: Official J Controlled Release Soc. 2019;295:140\u201352.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"1824_CR14","doi-asserted-by":"publisher","first-page":"5044","DOI":"10.1021\/acsomega.8b00341","volume":"3","author":"N Kimura","year":"2018","unstructured":"Kimura N, Maeki M, Sato Y, Note Y, Ishida A, Tani H, Harashima H, Tokeshi M. Development of the iLiNP device: fine tuning the lipid nanoparticle size within 10 Nm for drug delivery. ACS Omega. 2018;3:5044\u201351.","journal-title":"ACS Omega"},{"key":"1824_CR15","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jconrel.2022.12.020","volume":"353","author":"MA Younis","year":"2023","unstructured":"Younis MA, Sato Y, Elewa YHA, Kon Y, Harashima H. Self-homing nanocarriers for mRNA delivery to the activated hepatic stellate cells in liver fibrosis. J Controlled Release: Official J Controlled Release Soc. 2023;353:685\u201398.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"1824_CR16","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jconrel.2023.08.021","volume":"361","author":"MA Younis","year":"2023","unstructured":"Younis MA, Sato Y, Elewa YHA, Harashima H. Reprogramming activated hepatic stellate cells by siRNA-loaded nanocarriers reverses liver fibrosis in mice. J Controlled Release: Official J Controlled Release Soc. 2023;361:592\u2013603.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"1824_CR17","doi-asserted-by":"publisher","first-page":"8395","DOI":"10.2147\/IJN.S188016","volume":"13","author":"N Shobaki","year":"2018","unstructured":"Shobaki N, Sato Y, Harashima H. Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targeting. Int J Nanomed. 2018;13:8395\u2013410.","journal-title":"Int J Nanomed"},{"key":"1824_CR18","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature18300","volume":"534","author":"LM Kranz","year":"2016","unstructured":"Kranz LM, Diken M, Haas H, Kreiter S, Loquai C, Reuter KC, Meng M, Fritz D, Vascotto F, Hefesha H, Grunwitz C, Vormehr M, H\u00fcsemann Y, Selmi A, Kuhn AN, Buck J, Derhovanessian E, Rae R, Attig S, Diekmann J, Jabulowsky RA, Heesch S, Hassel J, Langguth P, Grabbe S, Huber C, T\u00fcreci \u00d6, Sahin U. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature. 2016;534:396\u2013401.","journal-title":"Nature"},{"key":"1824_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jconrel.2019.09.009","volume":"313","author":"S Kimura","year":"2019","unstructured":"Kimura S, Khalil IA, Elewa YHA, Harashima H. Spleen selective enhancement of transfection activities of plasmid DNA driven by octaarginine and an ionizable lipid and its implications for cancer immunization. J Controlled Release: Official J Controlled Release Soc. 2019;313:70\u20139.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"1824_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","volume":"150","author":"PK Smith","year":"1985","unstructured":"Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150:76\u201385.","journal-title":"Anal Biochem"},{"key":"1824_CR21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jconrel.2021.01.005","volume":"330","author":"S Kimura","year":"2021","unstructured":"Kimura S, Khalil IA, Elewa YHA, Harashima H. Novel lipid combination for delivery of plasmid DNA to immune cells in the spleen. J Controlled Release: Official J Controlled Release Soc. 2021;330:753\u201364.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"1824_CR22","doi-asserted-by":"publisher","first-page":"2303795","DOI":"10.1002\/adfm.202303795","volume":"33","author":"MM Abd Elwakil","year":"2023","unstructured":"Abd Elwakil MM, Suzuki R, Khalifa AM, Elshami RM, Isono T, Elewa YHA, Sato Y, Nakamura T, Satoh T, Harashima H. Harnessing topology and stereochemistry of Glycidylamine-Derived lipid nanoparticles for in vivo mRNA delivery to immune cells in spleen and their application for Cancer vaccination. Adv Funct Mater. 2023;33:2303795.","journal-title":"Adv Funct Mater"},{"key":"1824_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jconrel.2021.01.021","volume":"331","author":"MA Younis","year":"2021","unstructured":"Younis MA, Khalil IA, Elewa YHA, Kon Y, Harashima H. Ultra-small lipid nanoparticles encapsulating Sorafenib and midkine-siRNA selectively-eradicate Sorafenib-resistant hepatocellular carcinoma in vivo. J Controlled Release: Official J Controlled Release Soc. 2021;331:335\u201349.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"1824_CR24","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/pharmaceutics14081572","volume":"14","author":"K Sasaki","year":"2022","unstructured":"Sasaki K, Sato Y, Okuda K, Iwakawa K, Harashima H. mRNA-Loaded lipid nanoparticles targeting dendritic cells for Cancer immunotherapy. Pharmaceutics. 2022;14:1572.","journal-title":"Pharmaceutics"},{"key":"1824_CR25","doi-asserted-by":"publisher","first-page":"eaau6085","DOI":"10.1126\/sciimmunol.aau6085","volume":"4","author":"SM Lewis","year":"2019","unstructured":"Lewis SM, Williams A, Eisenbarth SC. Structure and function of the immune system in the spleen. Sci Immunol. 2019;4:eaau6085.","journal-title":"Sci Immunol"},{"key":"1824_CR26","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jconrel.2023.03.052","volume":"362","author":"S Kimura","year":"2023","unstructured":"Kimura S, Harashima H. On the mechanism of tissue-selective gene delivery by lipid nanoparticles. J Controlled Release: Official J Controlled Release Soc. 2023;362:797\u2013811.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"1824_CR27","doi-asserted-by":"crossref","unstructured":"Younis MA, Khalil IA, Abd Elwakil MM, Harashima H. A multifunctional Lipid-Based nanodevice for the highly specific codelivery of Sorafenib and midkine SiRNA to hepatic Cancer cells. Mol Pharm. 2019;16:4031\u201344.","DOI":"10.1021\/acs.molpharmaceut.9b00738"},{"key":"1824_CR28","doi-asserted-by":"publisher","first-page":"101754","DOI":"10.1016\/j.apmt.2023.101754","volume":"31","author":"M Maeki","year":"2023","unstructured":"Maeki M, Okada Y, Uno S, Sugiura K, Suzuki Y, Okuda K, Sato Y, Ando M, Yamazaki H, Takeuchi M, Ishida A, Tani H, Harashima H, Tokeshi M. Mass production system for RNA-loaded lipid nanoparticles using piling up microfluidic devices. Appl Mater Today. 2023;31:101754.","journal-title":"Appl Mater Today"},{"key":"1824_CR29","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","volume":"10","author":"HH Gustafson","year":"2015","unstructured":"Gustafson HH, Holt-Casper D, Grainger DW, Ghandehari H. Nanoparticle uptake: the phagocyte problem. Nano Today. 2015;10:487\u2013510.","journal-title":"Nano Today"},{"key":"1824_CR30","doi-asserted-by":"publisher","first-page":"15515","DOI":"10.1074\/jbc.271.26.15515","volume":"271","author":"H Saito","year":"1996","unstructured":"Saito H, Minamida T, Arimoto I, Handa T, Miyajima K. Physical States of surface and core lipids in lipid emulsions and Apolipoprotein binding to the emulsion surface*. J Biol Chem. 1996;271:15515\u201320.","journal-title":"J Biol Chem"},{"key":"1824_CR31","doi-asserted-by":"publisher","first-page":"13294","DOI":"10.1039\/D1NR02503A","volume":"13","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Sharmin R, Sigaeva A, Klijn CWM, Mzyk A, Schirhagl R. Not all cells are created equal \u2013 endosomal escape in fluorescent nanodiamonds in different cells. Nanoscale. 2021;13:13294\u2013300.","journal-title":"Nanoscale"},{"key":"1824_CR32","doi-asserted-by":"publisher","first-page":"RP95999","DOI":"10.7554\/eLife.95999","volume":"13","author":"S Koike","year":"2024","unstructured":"Koike S, Tachikawa M, Tsutsumi M, Okada T, Nemoto T, Keino-Masu K, Masu M. Actin dynamics switches two distinct modes of endosomal fusion in yolk sac visceral endoderm cells. eLife. 2024;13:RP95999.","journal-title":"eLife"},{"key":"1824_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/bs.mcb.2015.06.019","volume":"130","author":"AE Bay","year":"2015","unstructured":"Bay AE, Schreiner R, Rodriguez-Boulan E. Structural and functional analysis of endosomal compartments in epithelial cells. Methods Cell Biol. 2015;130:271\u201388.","journal-title":"Methods Cell Biol"},{"key":"1824_CR34","doi-asserted-by":"publisher","first-page":"2300006","DOI":"10.1002\/anbr.202300006","volume":"3","author":"X Tang","year":"2023","unstructured":"Tang X, Zhang Y, Han X. Ionizable lipid nanoparticles for mRNA delivery. Adv NanoBiomed Res. 2023;3:2300006.","journal-title":"Adv NanoBiomed Res"},{"key":"1824_CR35","doi-asserted-by":"crossref","unstructured":"Yanez Arteta M, Kjellman T, Bartesaghi S, Wallin S, Wu X, Kvist AJ, Dabkowska A, Sz\u00e9kely N, Radulescu A, Bergenholtz J, Lindfors L. Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles. Proc Natl Acad Sci U S A. 2018;115:E3351\u201360.","DOI":"10.1073\/pnas.1720542115"},{"key":"1824_CR36","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1039\/D0BM01609H","volume":"9","author":"R Zhang","year":"2021","unstructured":"Zhang R, El-Mayta R, Murdoch TJ, Warzecha CC, Billingsley MM, Shepherd SJ, Gong N, Wang L, Wilson JM, Lee D, Mitchell MJ. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver. Biomaterials Sci. 2021;9:1449\u201363.","journal-title":"Biomaterials Sci"},{"key":"1824_CR37","unstructured":"National Institute of Health (NIH). Trial with BNT111 and Cemiplimab in combination or as single agents in patients with Anti-PD-1-refractory\/\u200bRelapsed, unresectable stage III or IV melanoma. https:\/\/clinicaltrials.gov\/study\/NCT04526899. Accessed on 2024\/09\/02."},{"key":"1824_CR38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41586-020-2537-9","volume":"585","author":"U Sahin","year":"2020","unstructured":"Sahin U, Oehm P, Derhovanessian E, Jabulowsky RA, Vormehr M, Gold M, Maurus D, Schwarck-Kokarakis D, Kuhn AN, Omokoko T, Kranz LM, Diken M, Kreiter S, Haas H, Attig S, Rae R, Cuk K, Kemmer-Br\u00fcck A, Breitkreuz A, Tolliver C, Caspar J, Quinkhardt J, Hebich L, Stein M, Hohberger A, Vogler I, Liebig I, Renken S, Sikorski J, Leierer M, M\u00fcller V, Mitzel-Rink H, Miederer M, Huber C, Grabbe S, Utikal J, Pinter A, Kaufmann R, Hassel JC, Loquai C, T\u00fcreci \u00d6. An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma. Nature. 2020;585:107\u201312.","journal-title":"Nature"},{"key":"1824_CR39","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jconrel.2012.09.009","volume":"163","author":"Y Sato","year":"2012","unstructured":"Sato Y, Hatakeyama H, Sakurai Y, Hyodo M, Akita H, Harashima H. A pH-sensitive cationic lipid facilitates the delivery of liposomal SiRNA and gene Silencing activity in vitro and in vivo. J Controlled Release: Official J Controlled Release Soc. 2012;163:267\u201376.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"1824_CR40","doi-asserted-by":"publisher","first-page":"8529","DOI":"10.1002\/anie.201203263","volume":"51","author":"M Jayaraman","year":"2012","unstructured":"Jayaraman M, Ansell SM, Mui BL, Tam YK, Chen J, Du X, Butler D, Eltepu L, Matsuda S, Narayanannair JK, Rajeev KG, Hafez IM, Akinc A, Maier MA, Tracy MA, Cullis PR, Madden TD, Manoharan M, Hope MJ. Maximizing the potency of SiRNA lipid nanoparticles for hepatic gene Silencing in\u2005vivo. Angew Chem Int Ed. 2012;51:8529\u201333.","journal-title":"Angew Chem Int Ed"},{"key":"1824_CR41","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bioactmat.2024.01.022","volume":"35","author":"S Yuan","year":"2024","unstructured":"Yuan S, Hu Q. Convergence of nanomedicine and neutrophils for drug delivery. Bioactive Mater. 2024;35:150\u201366.","journal-title":"Bioactive Mater"},{"key":"1824_CR42","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.dib.2018.08.090","volume":"20","author":"Y Takeda","year":"2018","unstructured":"Takeda Y, Kato T, Nemoto N, Araki A, Gazi MY, Nara H, Asao H. Systemic neutrophil migration and rapid consumption of neutrophils in the spleen. Data Brief. 2018;20:680\u20132.","journal-title":"Data Brief"},{"key":"1824_CR43","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.smim.2005.05.013","volume":"17","author":"B Le\u00f3n","year":"2005","unstructured":"Le\u00f3n B, L\u00f3pez-Bravo M, Ardav\u00edn C. Monocyte-derived dendritic cells. Semin Immunol. 2005;17:313\u20138.","journal-title":"Semin Immunol"},{"key":"1824_CR44","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1182\/blood-2012-07-445189","volume":"121","author":"H Matsushima","year":"2013","unstructured":"Matsushima H, Geng S, Lu R, Okamoto T, Yao Y, Mayuzumi N, Kotol PF, Chojnacki BJ, Miyazaki T, Gallo RL, Takashima A. Neutrophil differentiation into a unique hybrid population exhibiting dual phenotype and functionality of neutrophils and dendritic cells. Blood. 2013;121:1677\u201389.","journal-title":"Blood"},{"key":"1824_CR45","doi-asserted-by":"crossref","unstructured":"Clarke S, Barnes P. Inflammatory and Immune Mechanisms in COPD, in: S.M. Janes, editor Encyclopedia of Respiratory Medicine (Second Edition), Academic Press, Oxford, 2022, pp. 549\u2013558.","DOI":"10.1016\/B978-0-08-102723-3.00221-3"},{"key":"1824_CR46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1046\/j.1445-2197.2002.02450.x","volume":"72","author":"V Yao","year":"2002","unstructured":"Yao V, Platell C, Hall JC. Dendritic cells. ANZ J Surg. 2002;72:501\u20136.","journal-title":"ANZ J Surg"},{"key":"1824_CR47","doi-asserted-by":"publisher","first-page":"11230","DOI":"10.1039\/C9RA00818G","volume":"9","author":"MK Kim","year":"2019","unstructured":"Kim MK, Kim J. Properties of immature and mature dendritic cells: phenotype, morphology, phagocytosis, and migration. RSC Adv. 2019;9:11230\u20138.","journal-title":"RSC Adv"},{"key":"1824_CR48","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","volume":"37","author":"KL Rock","year":"2016","unstructured":"Rock KL, Reits E, Neefjes J. Present yourself! By MHC class I and MHC class II molecules. Trends Immunol. 2016;37:724\u201337.","journal-title":"Trends Immunol"},{"key":"1824_CR49","doi-asserted-by":"crossref","unstructured":"Herv\u00e9 J, Dubreil L, Tardif V, Terme M, Pogu S, Anegon I, Rozec B, Gauthier C, Bach JM, Blancou P. \u03b22-Adrenoreceptor agonist inhibits antigen cross-presentation by dendritic cells, Journal of immunology (Baltimore, Md.: 1950). 2013;190:3163\u20133171.","DOI":"10.4049\/jimmunol.1201391"},{"key":"1824_CR50","unstructured":"BioLegend APC, anti-mouse. H-2Kb bound to SIINFEKL Antibody. https:\/\/www.biolegend.com\/ja-jp\/products\/apc-anti-mouse-h-2kb-bound-to-siinfekl-antibody-7882. Accessed on 2025\/01\/10."},{"key":"1824_CR51","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","volume":"8","author":"SA Dilliard","year":"2023","unstructured":"Dilliard SA, Siegwart DJ. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat Reviews Mater. 2023;8:282\u2013300.","journal-title":"Nat Reviews Mater"},{"key":"1824_CR52","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng Q, Wei T, Farbiak L, Johnson LT, Dilliard SA, Siegwart DJ. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat Nanotechnol. 2020;15:313\u201320.","journal-title":"Nat Nanotechnol"},{"key":"1824_CR53","doi-asserted-by":"publisher","first-page":"e2109256118","DOI":"10.1073\/pnas.2109256118","volume":"118","author":"SA Dilliard","year":"2021","unstructured":"Dilliard SA, Cheng Q, Siegwart DJ. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc Natl Acad Sci USA. 2021;118:e2109256118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1824_CR54","doi-asserted-by":"publisher","first-page":"114417","DOI":"10.1016\/j.addr.2022.114417","volume":"188","author":"T Nakamura","year":"2022","unstructured":"Nakamura T, Sato Y, Yamada Y, Abd Elwakil MM, Kimura S, Younis MA, Harashima H. Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines. Adv Drug Deliv Rev. 2022;188:114417.","journal-title":"Adv Drug Deliv Rev"},{"key":"1824_CR55","doi-asserted-by":"publisher","first-page":"1771925","DOI":"10.1080\/2162402X.2020.1771925","volume":"9","author":"N Salomon","year":"2020","unstructured":"Salomon N, Vascotto F, Selmi A, Vormehr M, Quinkhardt J, Bukur T, Schr\u00f6rs B, L\u00f6ewer M, Diken M, T\u00fcreci \u00d6, Sahin U, Kreiter S. A liposomal RNA vaccine inducing neoantigen-specific CD4(+) T cells augments the antitumor activity of local radiotherapy in mice. Oncoimmunology. 2020;9:1771925.","journal-title":"Oncoimmunology"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01824-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01824-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01824-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T11:09:11Z","timestamp":1757156951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01824-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1824"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01824-w","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"24 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. All the experimental protocols involving animals were reviewed and approved by the Hokkaido University Animal Care Committee, Sapporo, Japan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}